STAGE IV SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8
Clinical trials for STAGE IV SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug attack tested for Tough-to-Treat sarcomas
Disease control Recruiting nowThis study is testing a new treatment approach for people with advanced soft tissue sarcomas, including leiomyosarcoma and dedifferentiated liposarcoma. It aims to find the safest dose and best schedule for combining the drug abemaciclib with chemotherapy (gemcitabine). The main …
Matched conditions: STAGE IV SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Major cancer trial aims to boost survival for Tough-to-Treat tumors
Disease control Recruiting nowThis large, late-stage trial is testing whether adding an immunotherapy drug (pembrolizumab) to standard chemotherapy (doxorubicin) works better than chemotherapy alone for people with advanced or inoperable sarcomas. The goal is to see if the combination helps patients live long…
Matched conditions: STAGE IV SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC